Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Cardiac Assist Devices Market to be Propelled by Rapidly Growing Geriatric Population

Transparency Market Research
Posted on: 28 Oct 16

Cardiac Assist Devices (CAD) are type of mechanical pumps that work along with the heart to improve its pumping efficiency and maintain the optimum blood flow throughout the body. Cardiac Assist Devices can be segmented in three types ventricular assist devices, intra-aortic balloon pumps (IABPs) and total artificial heart. Ventricular assist device (VAD) is a mechanical pump which takes blood from a lower chamber of the heart and pumps it to the body and vital organs. Ventricular devices are of two types right ventricular assist device (RVAD), left ventricular assist device (LVAD) and if both the ventricular assist devices are used they’re known as biventricular assist device (BIVAD). Intra-aortic balloon pump is a type of CAD device which increases myocardial oxygen perfusion and cardiac output at the same time. Total artificial heart is a device which replaces the lower chambers of heart and recovers failing heart by performing all functions of a normal heart.

The rapidly growing geriatric population and the rise in cardiovascular diseases worldwide are expected to boost the growth of the global cardiac assist devices market. Dearth of donor hearts for transplantation has also fuelled the demand for cardiac assist device implantation in patients suffering from severe heart complications. During the forecast horizon, technological advancements leading to more efficient and minimally invasive devices are anticipated to drive the growth of the global cardiac assist devices market.

Current Market Structure of Cardiac Assist Devices Industries at:

On the basis of the #type# of devices, the report segments the global cardiac assist devices market into right ventricular assist devices (RVAD), left ventricular assist devices, and biventricular assist devices (BIVAD). Further, intra-aortic balloon pumps and total artificial hearts are also available in the market. While intra-aortic balloon pumps increase myocardial oxygen perfusion and cardiac output at the same time, total artificial hearts replace the lower chambers of the heart. The demand for each of the types of devices has been analyzed in the report.

The report studies #the cardiac assist devices market# across North America, Europe, Asia Pacific, and Rest of the World. North America leads the overall market owing to the high number of heart failure cases diagnosed in the region, the highest of all regional segments, along with the availability of reimbursement coverage for CAD implantation procedures. Europe has emerged as the second largest region in the market. During the forecast horizon, Asia Pacific and Rest of the World are anticipated to register positive growth due to the presence of a large pool of patients suffering from cardiac diseases.

Describing the competitive landscape, the report profiles some of the key players in the global cardiac assist devices market such as ABIOMED Inc., Berlin Herat GmbH, HeartWare International Inc. MAQUET GmbH & Co. KG, Teleflex Incorporated, Thoratec Corporation, and SynCardia Systems Inc.

Editor's Details

Transparency Market Research

Last updated on: 28/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.